Skip to main content
Taylor & Francis Group Logo
    Advanced Search

    Click here to search products using title name,author name and keywords.

    • Login
    • Hi, User  
      • Your Account
      • Logout
      Advanced Search

      Click here to search products using title name,author name and keywords.

      Breadcrumbs Section. Click here to navigate to respective pages.

      Chapter

      Testing the female athlete
      loading

      Chapter

      Testing the female athlete

      DOI link for Testing the female athlete

      Testing the female athlete book

      Testing the female athlete

      DOI link for Testing the female athlete

      Testing the female athlete book

      ByKirsty M. Hicks, Anthony C. Hackney, Michael Dooley, Georgie Bruinvels
      BookSport and Exercise Physiology Testing Guidelines: Volume I – Sport Testing

      Click here to navigate to parent product.

      Edition 2nd Edition
      First Published 2022
      Imprint Routledge
      Pages 5
      eBook ISBN 9781003045281
      Share
      Share

      ABSTRACT

      Practitioners often pay close attention to the effect of circadian, diurnal and ultra-dian rhythms on exercise and health in athletes. However, in female athletes, the menstrual cycle, which is an infradian rhythm, is sometimes overlooked. This chapter presents a systematic framework for working with female athletes by providing insight into the implementation and interpretation of screening and monitoring tools. The fluctuations in sex hormones can be altered by pregnancy, by chronological age and through the use of hormonal contraceptives. The screening process will also highlight the potential need for, and focus of, education, in addition to identifying the best form(s) of monitoring. Monitoring day-to-day physical, physiological and psychological changes across the menstrual cycle can provide insight into menstrual health and identify any potential perturbations. Due to large intra- and inter-variability in the menstrual cycle and the common use of hormonal contraceptives, the screening and monitoring tools and subsequent interpretation must be tailored to the individual.

      T&F logoTaylor & Francis Group logo
      • Policies
        • Privacy Policy
        • Terms & Conditions
        • Cookie Policy
        • Privacy Policy
        • Terms & Conditions
        • Cookie Policy
      • Journals
        • Taylor & Francis Online
        • CogentOA
        • Taylor & Francis Online
        • CogentOA
      • Corporate
        • Taylor & Francis Group
        • Taylor & Francis Group
        • Taylor & Francis Group
        • Taylor & Francis Group
      • Help & Contact
        • Students/Researchers
        • Librarians/Institutions
        • Students/Researchers
        • Librarians/Institutions
      • Connect with us

      Connect with us

      Registered in England & Wales No. 3099067
      5 Howick Place | London | SW1P 1WG © 2022 Informa UK Limited